HuTu-80 Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The HuTu-80 cell line is derived from a human duodenal adenocarcinoma and serves as a valuable in vitro model for studying gastrointestinal cancer, particularly those affecting the small intestine. As an epithelial-like cell line, HuTu-80 is instrumental in exploring the cellular mechanisms underlying tumorigenesis, cancer progression, and response to various therapeutic agents. The cells exhibit characteristics typical of adenocarcinoma, such as aberrant growth patterns and the ability to proliferate under laboratory conditions, making them suitable for both basic research and drug discovery applications. HuTu-80 cells are commonly used to investigate signal transduction pathways involved in gastrointestinal cancers, including those mediated by growth factors and their receptors, which are critical in the development and progression of adenocarcinomas. Researchers also utilize this cell line to study the effects of chemotherapeutic agents and other anti-cancer compounds, providing insights into potential treatments for duodenal and other gastrointestinal cancers. Due to their origin and well-characterized nature, HuTu-80 cells are a robust model for cancer research, particularly in exploring the complex biology of gastrointestinal malignancies. |
|---|---|
| Organism | Human |
| Tissue | Duodenum |
| Disease | Adenocarcinoma |
| Synonyms | HUTU 80, Hutu 80, HuTu 80, HUTU-80, Hutu-80, HUTU80, HuTu80, Hutu80 |
Characteristics
| Age | 53 years |
|---|---|
| Gender | Male |
| Ethnicity | Caucasian |
| Morphology | Epithelial-like |
| Growth properties | Adherent |
Regulatory Data
| Citation | HuTu-80 (Cytion catalog number 300218) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1301 |
Biomolecular Data
| Receptors expressed | Bombesin |
|---|---|
| Antigen expression | Blood Type B, Rh+ |
| Isoenzymes | PGM3, 1-2, PGM1, 1-2, ES-D, 1, Me-2, 2, AK-1, 1, GLO-1, 2, G6PD, B, Phenotype Frequency Product: 0.0017 |
| Tumorigenic | Yes, in nude mice. Forms well differentiated papillary adenocarcinoma, (grade I) |
| Ploidy status | Aneuploid |
| Karyotype | (P12) hypodiploid to hyperdiploid with modal number = 46 |
Handling
| Culture Medium | EMEM (MEM Eagle), w: 2 mM L-Glutamine, w: 2.2 g/L NaHCO3, w: EBSS (Cytion article number 820100a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS and 1% NEAA |
| Dissociation Reagent | Accutase |
| Doubling time | 26 to 30 hours |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 1 to 2 x 104 cells/cm2 is recommended |
| Fluid renewal | 2 to 3 times per week |
| Post-Thaw Recovery | Fast |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 300218-200825 | Certificate of Analysis | 05. Dec. 2025 | 300218 |
| 300218-618 | Certificate of Analysis | 23. May. 2025 | 300218 |